Advertisement



FDA Issues Draft Guidance to Cut Unnecessary Animal Testing for Cancer Drugs

Based on information published by FDA Press Releases (linked below the article). How we report

The U.S. Food and Drug Administration today issued a draft guidance to reduce unnecessary animal testing in nonclinical safety assessments for certain cancer drugs.


Advertisement



Important: this content is for informational purposes only and is not medical advice, a prescribing instruction, or a recommendation to act. Consult a licensed healthcare professional before taking any medication.


Related News

Advertisement